Načítá se...
Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma
Background: The cyclin-dependent-kinase inhibitors (CDKN)/retinoblastoma (RB1) pathway has been implicated as having a role in medullary thyroid carcinoma (MTC) tumorigenesis. CDKN2C loss has been associated with RET-mediated MTC in humans but with minimal phenotypic correlation provided. The object...
Uloženo v:
| Vydáno v: | Thyroid |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6453497/ https://ncbi.nlm.nih.gov/pubmed/27610696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2016.0224 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|